Marcy l'Etoile, France - July 24, 2009. First-Half 2009 Sales
- Up 6% at constant exchange rates and scope of consolidation
- Up 10.3% at constant exchange rates, including business development agreements
bioMérieux, a world leader in the field of in vitro diagnostics, today released its interim review for the six months ended June 30, 2009.
Net sales amounted to €590 million in the first half of 2009, an increase of 6% at constant exchange rates and scope of consolidation (like-for-like) over the first six months of 2008. Including the growth generated by recent business development agreements, the increase amounted to 10.3%.
In an international economic environment that has been much more challenging since September 2008, sales rose by 5.7% in the second quarter 2009, despite comparison with the strong 9.1% gain reported in the prior-year period.
Download
- Filename
- bmx_pr_ventes_s12009_gb22.pdf
- Size
- 44 KB
- Format
- application/pdf